Effects of Kettlebell Swing Training Combined With Breathing Exercises on Respiratory Muscle Strength and Pulmonary Function in Overweight and Obese Young Adults (Kettlebell)
Overweight and obesity are associated with impaired breathing mechanics, including reduced chest wall and diaphragmatic movement, decreased respiratory muscle strength and endurance, and inefficient breathing patterns. These changes may adversely affect pulmonary function, autonomic regulation, and physical capacity.
This study aims to compare the effects of kettlebell swing exercise combined with breathing training versus breathing training alone in individuals with overweight or obesity. Outcomes will include respiratory muscle strength, pulmonary function, heart rate variability, and body composition. The findings may help determine whether adding kettlebell swing exercise to breathing training provides additional benefits for respiratory and cardiometabolic health in this population.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
A total of 40 young adults aged 18-25 years with overweight or obesity (body mass index [BMI] ≥23.0 kg/m²) will be recruited and randomly assigned to one of two groups.
The experimental group will perform kettlebell swing exercise combined with breathing training for 40 minutes per session. The control group will receive breathing training alone for 20 minutes per session. Both groups will participate in their assigned intervention three times per week for 6 weeks.
Outcome measures will include respiratory muscle strength, pulmonary function, heart rate variability (HRV), and body composition.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Pacharee Manoy, Ph.D.
- Telefonnummer: Thailand: +66 (54) 466 697
- E-Mail: pachareeman@gmail.com
Studieren Sie die Kontaktsicherung
- Name: Patchareeya Amput, Ph.D.
- Telefonnummer: Thailand: +66 (54) 466 697
- E-Mail: patchareeya.am@up.ac.th
Studienorte
-
-
Changwat Phayao
-
Phayao, Changwat Phayao, Thailand, 56000
- Rekrutierung
- School of Allied Health Sciences, University of Phayao
-
Kontakt:
- Pacharee Manoy, Ph.D.
- Telefonnummer: 3339 Thailand: +66 (54) 466 666
- E-Mail: pacharee.ma@up.ac.th
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Male or female adults aged 18-25 years with a body mass index (BMI) of ≥23.0 kg/m².
- Individuals who are physically inactive or sedentary, defined as exercising fewer than 3 days per week or engaging in less than 150 minutes of exercise per week.
- Willingness to provide written informed consent to participate in the study.
Exclusion Criteria:
- Presence of bodily pain, particularly in the upper or lower extremities, with a Visual Analogue Scale (VAS) score of >3/10.
- Musculoskeletal disorders, such as scoliosis.
- History of neurological disorders, including spinal cord injury, epilepsy, or stroke.
- History of respiratory or cardiovascular diseases, including hypertension, heart disease, emphysema, asthma, previous lung lobectomy, or lung cancer.
- History of chronic non-communicable diseases or other systemic disorders, including diabetes mellitus, kidney disease, liver disease, endocrine disorders, or immune system disorders.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Experimental group
Kettlebell swing training combined with breathing exercises
|
Kettlebell swing training combined with breathing exercises, performed three times per week for 40 minutes per session over 6 weeks.
|
|
Schein-Komparator: Control group
Breathing exercises
|
Breathing exercises performed three times per week for 20 minutes per session over 6 weeks.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Repiratory muscle strength
Zeitfenster: Before and after the 6 week intervention
|
Respiratory muscle strength will be measured using a handheld manometer (MicroRPM).
Participants will be instructed to perform a maximal inspiratory effort from residual volume to assess maximal inspiratory pressure (PImax) and a maximal expiratory effort from total lung capacity to assess maximal expiratory pressure (PEmax).
|
Before and after the 6 week intervention
|
|
Heart rate variability (HRV)
Zeitfenster: Before and after the 6 week intervention
|
Time and frequency-domain heart rate variability (HRV) parameters will be measured using the SA-3000P analyzer.
|
Before and after the 6 week intervention
|
|
Pulmonary function test
Zeitfenster: Before and after the 6 week intervention
|
Vital capacity (VC), expiratory reserve volume (ERV), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), and the FEV₁/FVC ratio will be measured using a portable spirometer.
|
Before and after the 6 week intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Body composition
Zeitfenster: Before and after the 6 week intervention
|
Muscle mass and fat mass will be assessed using bioelectrical impedance analysis (BIA).
|
Before and after the 6 week intervention
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- HREC-UP-HSST 1.2/111/69
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .